Kestra Medical officer lists 8,817 shares for sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
KESTRA MEDICAL TECHNOLOGIES, LTD. officer Mahboob Vaseem's notice lists 8,817 common shares for sale, with an aggregate market value of $199,344.62 and an approximate sale date of July 31, 2026. The shares were acquired July 17, 2026, through vesting of performance share unit awards under the issuer's equity compensation plan. A separate past-three-months table reports 3,980 shares sold July 30 for gross proceeds of $90,560.62.
Key Figures
Key Terms
Aggregate Market Value financial
issuer equity compensation plan technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What prior sale does the KMTS notice report?
AI-generated analysis. How Rhea-AI works. Not financial advice.